Health condition
PRSS1 and SPINK1 testing
Genetic testing for PRSS1, SPINK1, CFTR and related genes clarifies why pancreatitis keeps recurring without an obvious cause, informs family decisions and flags those needing long-term cancer surveillance - but interpretation needs genetic counselling.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key points
What matters most, at a glance.
The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.
-
Testing is considered for recurrent or chronic pancreatitis that is unexplained, early-onset, or familial
-
PRSS1 gain-of-function variants behave as dominant disease genes; SPINK1 and CFTR variants act mainly as risk modifiers
-
A positive PRSS1 result changes management - lifestyle counselling, family cascade testing and cancer surveillance enrolment
-
A negative panel does not exclude a genetic contribution, and variants of uncertain significance require expert interpretation
-
Testing children is approached carefully, balancing early lifestyle benefit against autonomy, with specialist counselling
Understanding it
About PRSS1 and SPINK1 testing, and what to do next.
The genes map the pancreas’s internal safety systems: PRSS1 encodes trypsinogen itself, SPINK1 its first-line inhibitor, CFTR the duct-flushing chloride channel, and CTRC the enzyme that degrades rogue trypsin. Variants tilt the balance towards autodigestion - singly in dominant PRSS1 disease, or in combination in many so-called idiopathic cases.
The practical value of a result differs by gene, which is exactly why counselling wraps the test: PRSS1 positivity redefines a family’s risk and surveillance, while an isolated SPINK1 variant mainly explains rather than predicts. Insurance, reproductive options and testing of relatives are standard parts of the conversation. Most people start with their GP, who can refer to a consultant pancreatologist jointly with a clinical genetics service. In many parts of the UK, routine NHS referrals for this kind of problem currently take 20-45+ weeks, whereas an initial private consultation is typically available within around two weeks.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any emergency symptoms described above.
Frequently asked
Common questions about PRSS1 and SPINK1 testing.
Quick, plain-English answers to what people ask us most.
-
What are PRSS1 and SPINK1 genes, and why are they tested?
PRSS1 and SPINK1 are genes involved in regulating pancreatic enzyme activity; mutations in these genes are linked to hereditary and idiopathic chronic pancreatitis, so testing helps identify a genetic cause in some patients with recurrent or unexplained pancreatitis.
-
Who should consider PRSS1 and SPINK1 testing?
Testing is typically considered for people with recurrent acute pancreatitis or chronic pancreatitis without a clear cause (such as gallstones or alcohol), particularly with a family history or onset at a young age.
-
What does a PRSS1 mutation mean?
A PRSS1 mutation is linked to hereditary pancreatitis, an inherited condition causing recurrent pancreatitis episodes from a young age, typically in an autosomal dominant pattern with a strong family history.
-
What does a SPINK1 mutation mean?
A SPINK1 mutation is associated with an increased susceptibility to pancreatitis, often acting alongside other factors, rather than being a sole, direct cause in the same way as PRSS1 mutations.
-
How is this genetic testing performed?
Testing typically involves a simple blood sample, from which the relevant genes are analysed in a specialist genetic laboratory, usually arranged through a gastroenterology or genetics specialist.
-
Does having one of these mutations increase cancer risk?
Yes, particularly PRSS1-related hereditary pancreatitis is associated with an increased long-term risk of pancreatic cancer, which is why ongoing specialist monitoring is often recommended for confirmed carriers.
-
Can PRSS1 or SPINK1-related pancreatitis be treated?
Treatment focuses on managing pancreatitis episodes as they occur, addressing pain and nutritional needs, avoiding known triggers such as alcohol and smoking, and monitoring for long-term complications including diabetes and, where relevant, cancer risk.
-
PRSS1 vs SPINK1 testing — what's the difference in implications?
A PRSS1 mutation typically indicates a stronger, more directly causative genetic link to hereditary pancreatitis with higher associated cancer risk, while a SPINK1 mutation is more of a susceptibility factor, often needing to combine with other triggers; genetic counselling helps explain the specific implications for your situation.
-
Should family members be tested if a mutation is found?
Yes, genetic counselling is recommended for close relatives, as they may also carry the mutation and could benefit from awareness of their own pancreatitis and cancer risk and appropriate monitoring.
-
When should I see a specialist, and how quickly can I be seen privately?
See a gastroenterologist or genetic specialist if you have recurrent unexplained pancreatitis, particularly with a family history. Private specialist assessment is typically available within about two weeks, faster than standard NHS pathways for this specific testing.